Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
This arrangement has allowed pharmaceutical companies to move profits out of Ireland and book them in tax havens like Bermuda or the Cayman Islands, which impose no income taxes at all, and where companies have no actual business activity.
- Simplified Text
-
Licensing arrangement has allowed pharmaceutical companies to move profits out of Ireland and book them in tax havens like Bermuda or the Cayman Islands.
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "industry": "Pharmaceutical", "location": "Ireland, Bermuda, Cayman Islands" } - UUID
- 9fdb5dc8-0e90-4aed-844d-073a4e08c281
- Vector Index
- ✗ No vector
- Created
- September 12, 2025 at 2:46 AM (1 day ago)
- Last Updated
- September 12, 2025 at 2:46 AM (1 day ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
41
claims
🔥
1 day ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning®i_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.